← Back to Search

Lab Panel for Deep Vein Thrombosis

N/A

Waitlist Available

Led By Maria Hanna, MD

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 8- ≤ 21 years old AND lower extremity deep venous thrombosis OR lower extremity deep venous thrombosis AND pulmonary embolism OR pulmonary embolism

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up participants will be asked to fill this questionnaires 4 weeks after diagnosis, and 3-6 months after diagnosis.

Awards & highlights

Study Summary

This trial is studying if a new medication is effective in treating patients with venous thromboembolism.

Who is the study for?

This trial is for children and young adults aged 8 to 21 who have had a blood clot in the leg (deep vein thrombosis) or lung (pulmonary embolism). They must be able to undergo MRI scans, participate in exercise tests, and follow instructions. Those with recent surgery, immobility due to casts or fractures, developmental delays that affect understanding instructions, or congenital heart disease are not eligible.Check my eligibility

What is being tested?

The study is examining how blood clots affect the ability of these patients to exercise and their muscle energy production. It involves non-invasive tests like MRI scans of muscles at rest and after exercise, questionnaires about health status, and measuring physical fitness through bicycle ergometry along with routine lab panels.See study design

What are the potential side effects?

There may be minimal side effects associated with this trial as it primarily involves diagnostic procedures rather than medication. Possible side effects include discomfort from exercising if not used to it and mild reactions such as claustrophobia during an MRI scan.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 8 and 21 years old and have a blood clot in my leg or lungs.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ participants will be asked to fill out this questionnaire at one month post diagnosis.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~participants will be asked to fill out this questionnaire at one month post diagnosis.

This trial's timeline: 3 weeks for screening, Varies for treatment, and participants will be asked to fill out this questionnaire at one month post diagnosis. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Assessment for Venous Occlusion

Assessment of Lymphatic flow

Coagulation markers

+2 more

Secondary outcome measures

Exercise Intolerance

Godin Leisure Time Activity Questionnaire

Sleep Apnea Syndromes

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Venous Thromboembolism ArmExperimental Treatment4 Interventions

This will be a cohort of patients age 8- ≤ 21 years old with objectively diagnosed DVT and/or PE.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Questionnaires

2013

Completed Phase 2

~3330

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor

1,047 Previous Clinical Trials

1,053,769 Total Patients Enrolled

4 Trials studying Deep Vein Thrombosis

390 Patients Enrolled for Deep Vein Thrombosis

Maria Hanna, MDPrincipal InvestigatorUniversity of Texas Southwestern Medical Center

Ayesha Zia, MDPrincipal InvestigatorUniversity of Texas Southwestern Medical Center

1 Previous Clinical Trials

50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still capacity for participants in this trial?

"According to the clinicaltrials.gov page, this medical trial is no longer accepting patients at this time: it was first posted on February 6th 2020 and last updated on January 21st 2022. However, there are 213 other trials currently looking for volunteers in related fields of research."

Answered by AI

What are the fundamental goals of this medical experiment?

"The primary metric to be evaluated with the aid of Arterial Spin labeling MRI will be coagulation markers, while secondary parameters include OSA-18 Sleep apnea Questionnaire, Godin Leisure Time Activity Questionnaire and Exercise Intolerance (the latter being measured through Cardiopulmonary Exercise testing). Data collection for all these outcomes is set to take place between 3-6 months post diagnosis."

Answered by AI

Am I eligible to take part in this research program?

"This research is targeting 30 individuals aged 8 to 21 who are suffering from a pulmonary embolism or lower extremity deep venous thrombosis. To be eligible for participation, patients must satisfy all of the previously mentioned criteria."

Answered by AI

Does the study limit participation to individuals 60 years or younger?

"The criteria for participation in this medical trial is between the ages of 8 and 21. There are 14 studies dedicated to minors while 202 cater toward elderly patients over 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis

Ayesha Zia 2020. "Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04294849.

All > Pulmonary Embolism